Showing results (201-210 of 324) with videos related to
Sort By:
Pageof 33
Cancers|May 18, 2019
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/MyxofibrosarcomaAnthony P Conley, Wei-Lien Wang, John A Livingston, et al.JAMA Oncology|March 10, 2022
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in FloridaAnna R Giuliano, Jeffrey E Lancet, Shari Pilon-Thomas, et al.Cancer Discovery|April 17, 2019
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid TumorsSalah-Eddine Bentebibel, Michael E Hurwitz, Chantale Bernatchez, et al.Journal of Translational Medicine|June 6, 2022
Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to malesMariam Saad, Sandra J Lee, Aik Choon Tan, et al.Cancers|October 28, 2023
The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint InhibitorsIslam Eljilany, Payman Ghasemi Saghand, James Chen, et al.Molecular Cancer Therapeutics|August 13, 2009
Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlatesScott E Woodman, Jonathan C Trent, Katherine Stemke-Hale, et al.Melanoma Research|June 7, 2012
A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanomaKevin B Kim, Victor Prieto, Richard W Joseph, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanomaSteven A Rosenberg, James C Yang, Douglas J Schwartzentruber, et al.Scientific Reports|September 9, 2023
A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironmentCheng-Hsin Wei, Lu Huang, Blair Kreh, et al.Journal of Translational Medicine|June 3, 2021
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy)Paolo A Ascierto, Carlo Bifulco, Fortunato Ciardiello, et al.Pageof 33